Keros Therapeutics (KROS) Earnings Date & Reports

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

KROS is expected to report earnings to fall 130.39% to -110 cents per share on July 31

Keros Therapeutics KROS Stock Earnings Reports

Q2'25

Est.

$-1.10

Q1'25

Beat

by $4.81

Q4'24

Beat

by $0.22

Q3'24

Missed

by $0.13

Q2'24

Beat

by $0.01

The last earnings report on May 06 showed earnings per share of $3.62, beating the estimate of -119 cents. With 43.74K shares outstanding, the current market capitalization sits at 572.68M.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+30%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

KROS